Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hotung Venture Capital is a Taiwan-based venture capital and investment management firm within the Hotung Venture Group ecosystem. The organization focuses on venture investing rather than operating as a drug developer, pharmaceutical company, CRO, or healthcare services provider. Public descriptions indicate it has invested broadly across innovative technology businesses and has historically operated as part of Hotung Investment Holdings, alongside other investment subsidiaries. The group reports a long operating history dating back to the late 1980s and a large cumulative portfolio across Taiwan, Greater China, the United States, and other markets. For biotech analysts, the key point is that Hotung Venture Capital is primarily an investor in companies, including occasional healthcare-related portfolio companies, not a therapeutic product company with an internal R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hotung Venture Capital.